Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine

Dosing with vormatrigine over 8 weeks led to 56.3% median reduction in seizure frequency